Position in AVXL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$259
-$48 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#172
of 179 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026S&T Bank/PA holds $4,851,787 across 8 Biotechnology names. AVXL ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
55,553 | $4,830,333 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $4,988 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
18 | $4,337 | |
| 4 | INSM |
INSMED Inc
|
37 | $3,944 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12 | $3,612 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5 | $2,483 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
32 | $1,831 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
This page
|
100 | $259 |
All Filings in AVXL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259 | 100 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $307 | 100 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $356 | 100 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $890 | 100 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $922 | 100 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $858 | 100 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,074 | 100 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||